What lab findings suggest Hemophagocytic Lymphohistiocytosis (HLH)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Laboratory Findings Suggestive of Hemophagocytic Lymphohistiocytosis (HLH)

Hyperferritinemia is the most characteristic laboratory finding in HLH, with levels >7000-10,000 μg/L strongly suggestive of HLH in adults, and should always prompt consideration of this diagnosis. 1

Key Diagnostic Laboratory Parameters

According to the HLH-2004 diagnostic criteria, laboratory findings that suggest HLH include:

  1. Cytopenias affecting ≥2 of 3 lineages:

    • Hemoglobin <90 g/L
    • Platelets <100 × 10⁹/L
    • Neutrophils <1.0 × 10⁹/L
  2. Hyperferritinemia:

    • Ferritin ≥500 μg/L (diagnostic threshold)
    • Ferritin >7000-10,000 μg/L (highly suggestive in adults)
    • Ferritin >10,000 μg/L (>90% sensitive and specific in children)
  3. Coagulation abnormalities:

    • Hypertriglyceridemia (fasting triglycerides ≥3.0 mmol/L or ≥265 mg/dL)
    • Hypofibrinogenemia (fibrinogen ≤1.5 g/L)
  4. Elevated soluble IL-2 receptor (sCD25):

    • ≥2400 U/mL
    • Better diagnostic marker than ferritin (AUC 0.90 vs 0.78) 1
  5. Low or absent NK cell activity (according to local laboratory reference) 1

Additional Laboratory Findings

Other laboratory abnormalities that support the diagnosis include:

  • Elevated liver enzymes (AST ≥30 U/L) 1
  • Hypoproteinemia
  • Hyponatremia
  • Elevated VLDL and decreased HDL
  • Elevated LDH
  • Hemophagocytosis on bone marrow aspirate (neither sensitive nor specific) 1

Diagnostic Approach

To diagnose HLH, 5 of the 8 HLH-2004 criteria must be fulfilled, or a molecular diagnosis consistent with HLH must be established 1. However, it's important to note that:

  1. The HLH-2004 criteria were developed for children and are not formally validated for adults 1
  2. In the context of malignancy, several criteria may be present due to the underlying disease rather than HLH 1
  3. Hemophagocytosis, despite the name of the syndrome, is neither sensitive nor specific for HLH 1

Monitoring Disease Activity

Certain laboratory parameters can be used to monitor disease activity and treatment response:

  • Platelet count (rapidly reflects HLH activity)
  • Ferritin (increases rapidly but normalizes slowly)
  • Fibrinogen
  • sCD25 levels
  • LDH 1

Clinical Context

The likelihood of underlying malignancy increases with age:

  • 60 years: 68% have lymphoma

  • 30-59 years: 38% have lymphoma
  • 15-29 years: 10% have lymphoma
  • <14 years: 0% have lymphoma 1

Pitfalls and Caveats

  1. Ferritin interpretation: While highly elevated ferritin is characteristic, it's less specific in adults than in children and can be elevated in other conditions like iron overload 1

  2. Hemophagocytosis: May be absent initially and can be present in other conditions like septicemia 1

  3. Cytopenias: May be due to underlying malignancy, infection, or treatment rather than HLH 1

  4. Diagnostic delay: Laboratory findings may evolve over time, requiring serial testing if HLH is strongly suspected despite not meeting full criteria initially 1

  5. Malignancy masking: In patients with known malignancy, distinguishing disease-related abnormalities from HLH can be challenging 1

When laboratory findings suggest possible HLH, a thorough search for underlying triggers (especially malignancy in adults) should be initiated, as prompt diagnosis and treatment are essential to prevent mortality 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.